Erythromycin E_x000b_Discontinued
|
|
|
- CAS-Nr.
- 41451-91-6
- Englisch Name:
- Erythromycin E_x000b_Discontinued
- Synonyma:
- erythromycin E;Erythromycin Imp-C;1',15-Oxyerythromycin;1'',16-Epoxy-erythromycin;Erythromycin EP Impurity C;PRUSTPADOGZAML-NSZHHLGZSA-N;Erythromycin E Discontinued;Erythromycin,1'',16-epoxy- (9CI);Erythromycin E_x000b_Discontinued;Erythromycin E,Erythromycin Impurity C
- CBNumber:
- CB81176306
- Summenformel:
- C37H65NO14
- Molgewicht:
- 747.91
- MOL-Datei:
- 41451-91-6.mol
|
Erythromycin E_x000b_Discontinued Eigenschaften
- Siedepunkt:
- 833.2±65.0 °C(Predicted)
- Dichte
- 1.25±0.1 g/cm3(Predicted)
- pka
- 13.08±0.70(Predicted)
Sicherheit
Erythromycin E_x000b_Discontinued Chemische Eigenschaften,Einsatz,Produktion Methoden
Erythromycin E_x000b_Discontinued Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Erythromycin E_x000b_Discontinued Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 67)Lieferanten
- 1'',16-Epoxy-erythromycin
- Erythromycin E Discontinued
- Spiro[5H,11H-1,3-dioxino[5,4-c]oxacyclotetradecin-2,2'-[2H]pyran] Erythromycin Derivativ
- erythromycin E
- Spiro[5H,11H-1,3-dioxino[5,4-c]oxacyclotetradecin-2,2'-[2H]pyran] Erythromycin Derivative
- 1',15-Oxyerythromycin
- PRUSTPADOGZAML-NSZHHLGZSA-N
- Erythromycin Impurit C:(erythromycin E)
- Erythromycin,1'',16-epoxy- (9CI)
- Erythromycin Impurity 3(Erythromycin EP Impurity C)
- Erythromycin EP Impurity C/Erythromycin E/(2S,4aR,4'R,5'S,6'S,7R,8S,9R,10R,12R,14R,15R,16S,16aS)-15-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-7-ethyl-5',8,9,14-tetrahydroxy-4'-methoxy-4',6',8,10,12,14,16-heptamethyl
- Erythromycin EP Impurity C (Erythromycin E)
- (2S,4R,4a'R,5S,6S,7'R,8'S,9'R,10'R,12'R,14'R,15'R,16'S,16a'S)-15'-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-7'-ethyl-5,8',9',14'-tetrahydroxy-4-methoxy-4,6,8',10',12',14',16'-heptamethylhexadecahydro-5'H,11'H-spiro[
- Erythromycin E,Erythromycin Impurity C
- Erythromycin Imp-C
- (2S,4R,4a'R,5S,6S,7'R,8'S,9'R,10'R,12'R,14'R,15'R,16'S,16a'S)-15'-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-7'-ethyl-5,8',9',14'-tetrahydroxy-4-methoxy-4,6,8',10',12',14',16'-heptamethylhexadecahydro-5'H,11'H-spiro[pyran-2,2'-[1,3]dioxino[5,4-c][1]oxacyclotetradecine]-5',11'-dione
- Erythromycin E_x000b_Discontinued
- Erythromycin E_x005f_x000b_Discontinued
- Erythromycin EP Impurity C
- (2S,4aR,4'R,5'S,6'S,7R,8S,9R,10R,12R,14R,15R,16S,16aS)-15-(((2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-7-ethyl-5',8,9,14-tetrahydroxy-4'-methoxy-4',6',8,10,12,14,16-heptamethylhexadecahydrospiro[[1,3]dioxino[5,4-c][1]oxacyclotetradecine-2,2'-pyran]-5,11-dione (Erythromycin Impurity)
- (2S,4aR,4'R,5'S,6'S,7R,8S,9R,10R,12R,14R,15R,16S,16aS)-15-(((2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-7-ethyl-5',8,9,14-tetrahydroxy-4'-methoxy-4',6',8,10,12,14,16-heptamethylhexadecahydrospiro[[1,3]dioxino[5,4-c][1]oxacyclotetradecine-2,2'-pyran]-5,11-dione (Erythromycin Impurity)
- 41451-91-6
- C37H65NO14
- Intermediates & Fine Chemicals
- Pharmaceuticals
- Pharmaceuticals, Intermediates & Fine Chemicals
